This week, Natural Products Expo West 2025 showcased trends in the natural and organic sectors from nearly 3,200 exhibitors. The show especially highlighted the impact of GLP-1 drugs on snacking habits.
The growing popularity of GLP-1 weight-loss drugs is reshaping the yogurt market, as consumers increasingly seek protein-packed snacks. Multiple brands are innovating with high-protein, low-sugar options.
The rapid adoption of weight-loss drugs is reshaping purchasing habits. Circana experts highlight opportunities for brands to align with GLP-1 users’ goals by offering tailored, portion-controlled products and leveraging personalized marketing strategies to capture this evolving market.
Alcohol manufacturers, retailers, and foodservice segments have a lot to worry about heading into the new year, with Dry January and Surgeon General advisories advocating for sober-curious lifestyles. Time will tell if these movements make an impact.
Nestlé is tapping into the booming weight-loss market with Boost Pre-Meal Hunger Support, a 45-calorie whey-protein solution designed to reduce appetite. Experts caution consumers about the shots’ limited effectiveness.
GLP-1 weight-loss drugs are transforming dieting culture, offering a relatively easy solution to weight loss. While these drugs may disrupt food consumption patterns, their long-term impact hinges on overcoming high dropout rates and premium pricing, one industry insider says.
With dreams of CPG integration, FitBiomics is producing probiotics designed by data mining the gut microbiomes of professional athletes. Is this the next big wellness trend?
GLP-1 weight-loss drugs are increasing consumers’ preference toward healthier, nutrient-dense food. Some trends experts feel reduced demand for high-calorie foods could hurt QSRs, at least in the near-term.
New research, conducted by food innovation firm Mattson, revealed that GLP-1 users have reported specific food preferences, including more protein and smaller portions.
From GLP-1 injectables to mushroom-based coffee alternatives, the booming supplement market is making nutrition easier to manipulate.
The market for GLP-1 drugs is expected to reach $100 billion by 2030. Manufacturers and brands who want a piece of the low-sugar pie, so to speak, will have to offer the same.
The latest Food Institute Fast Break news podcast touches on the trend of “AI washing” by some major businesses.
Across the U.S, social chatter is shaping wellness conversations and boosting demand for related ingredients. Here are three wellness trends to watch, according to a new report from Brightfield Group. Immunity Now Within Brightfield’s Wellness …
With the New Year underway, which health and wellness trends are food consumers gravitating towards? Which should the food industry focus on?
The recent rise of Ozempic and other weight-loss drugs started with blowout results that drove shares of their manufacturers higher, then wound up cascading across seemingly disparate sectors. In 2023, Novo Nordisk, the manufacturer of …
Eli Lilly’s Zepbound, recently approved by the FDA, is the most potent weight-loss drug yet. Could it impact the food industry? At least one expert says ‘yes.’
The latest Fast Break Food Institute news podcast touches on “The Ozempic Effect” on the food and beverage industry.
With 17% of children ages 10 to 17 considered obese, consideration is being given to whether diabetes drugs like Ozempic should be made available to kids. Health experts have concerns.
Blockbuster diabetes drugs like Ozempic and Wegovy, which have become the darlings of the weight-loss industry, could have an unintended side-effect: shrinking the bottom lines of major snack-making companies. Junk food has been widely blamed …
This week’s Food Institute news podcast touches on the latest innovations featured at fast-food drive-thrus.
Several medications approved to treat diabetes are being used as “miracle” weight-loss drugs, and the category continues to grow.
